Loading...
•
Dec 31, 2020
Accuray Q2 2021 Earnings Report
Reported financial results for the second quarter of fiscal year 2021.
Key Takeaways
Accuray Incorporated reported a net revenue of $97.5 million for the second quarter of fiscal year 2021, which includes $21.3 million of system revenue in China. The company's GAAP operating income was $8.2 million and GAAP net income was $4.8 million. Adjusted EBITDA grew to $13.5 million. They also received FDA clearance for ClearRT™ Helical kVCT Imaging for the Radixact® System.
Net revenue of $97.5 million including $21.3 million of system revenue in China.
Gross orders of $75.4 million, ending backlog of $596.2 million, an increase of 11 percent from December 31, 2019.
GAAP operating income of $8.2 million and GAAP net income of $4.8 million, compared to GAAP operating income of $3.6 million and GAAP net income of $10.7 million in the prior year second quarter.
Adjusted EBITDA grew to $13.5 million from $7.1 million in the prior year second quarter.
Revenue by Segment
Forward Guidance
Accuray believes it is prudent to refrain from providing financial guidance for fiscal year 2021 due to the continued evolution of the COVID-19 pandemic and the uncertainty surrounding its impact on the global economy and the healthcare industry.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...